News from perrigo A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:PRGO,TelAviv:PRGO)

Nov 20, 2014, 20:05 ET
Perrigo Company

Perrigo Company plc Announces the Pricing of its Offering of Ordinary Shares

  Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today...

Nov 20, 2014, 06:49 ET
Perrigo Company.

Perrigo Company plc Announces Proposed Public Offering Of Ordinary Shares

 Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today...

Nov 13, 2014, 08:50 ET
Store Brand Formula

Survey Finds Infant Feeding Tops List of Questions New Parents Ask Pediatricians

New parents often have an endless list of questions about caring for their little ones, and the pediatrician serves as a go-to resource for...

Nov 06, 2014, 06:39 ET
Perrigo Company.

Perrigo Reinitiates Shipments Of Guaifenesin Extended-Release 600mg Tablets, The Store Brand Equivalent To Mucinex® 600mg Extended-Release Tablets

Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its...

Nov 06, 2014, 06:32 ET
Perrigo Company.

Perrigo Company PLC Reports Record First Quarter Revenue, Adjusted Net Income And Adjusted Margins

  - Fiscal first quarter net sales increased to a first quarter record of $952 million. - Fiscal first quarter adjusted net income...

Nov 06, 2014, 06:26 ET
Perrigo Company.

Perrigo Company plc To Acquire Omega Pharma NV For EUR 3.6 Billion Creating A Top Five Global OTC Company

 Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," and Omega Pharma NV, one...

Nov 03, 2014, 15:12 ET
Perrigo Company.

Perrigo Company plc Announces Quarterly Dividend

Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on...

Oct 23, 2014, 08:34 ET
Perrigo Company.

Perrigo Company plc To Release First Quarter Fiscal Year 2015 Results On November 6, 2014

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its first quarter fiscal year 2015 on Thursday,...

Oct 14, 2014, 10:25 ET
Perrigo Animal Health Logo

Perrigo Animal Health Receives SQF Certification

 Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), is proud to announce that its Kansas City, Kansas, manufacturing...

Oct 02, 2014, 08:48 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043

 Perrigo Company plc (NYSE: PRGO; TASE), a public limited company incorporated under the laws of Ireland (the "Company"), today announced the...

Oct 01, 2014, 08:53 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Extension of Exchange Offer for Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043

 Perrigo Company plc (NYSE: PRGO; TASE), a public limited company incorporated under the laws of Ireland (the "Company"), today announced...

Sep 29, 2014, 07:39 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals

 Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has transferred a portfolio of preclinical research assets, which it acquired...

Sep 29, 2014, 07:09 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Enters New Therapeutic Category With The Acquisition Of Women's Health Product Portfolio From Lumara Health

 Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has signed a definitive agreement to acquire a portfolio of women's healthcare...

Sep 02, 2014, 17:09 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043

Perrigo Company plc, a public limited company incorporated under the laws of Ireland (the "Company"), today announced that it is offering to...

Aug 14, 2014, 09:41 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Reports Record Fourth Quarter And Fiscal Year Revenue, Adjusted Operating Income And Adjusted Margins. Conference call scheduled for 10 a.m. ET today.

- Fiscal fourth quarter net sales increased 18% year-over-year to a record $1.14 billion. - Fiscal fourth quarter adjusted net income...

Aug 13, 2014, 15:49 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc Announces Quarterly Dividend

Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on...

Jul 31, 2014, 08:58 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Company plc To Release Fourth Quarter And Fiscal Year 2014 Results On August 14, 2014

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its fourth quarter and fiscal year 2014 on...

Jul 30, 2014, 08:10 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25%

Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application...

Jul 24, 2014, 12:55 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%

 Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug...

Jul 08, 2014, 08:47 ET
Perrigo Company.  (PRNewsFoto/Perrigo Company)

Perrigo Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg

Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for...